Latest Medical Research News and Research
Updated: 48 min 48 sec ago
Gunshots crackled as a man dressed in camouflage sat on the ground with a red stream trickling from his ear and a purple splotch marking the skin near his cheekbone. A medic asked what happened.
People with major depressive disorder have alterations in the activity and connectivity of brain systems underlying reward and memory, according to a new study by the University of Warwick.
The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections.
An alternative animal model that mimics key features of the Zika virus infection, including its lingering presence in bodily fluids, has been developed at Texas Biomedical Research Institute in San Antonio.
Researchers from Instituto de Medicina Molecular João Lobo Antunes have found a mechanism through which certain types of leukemia resist chemotherapy, thus revealing novel molecular targets that may be used to improve the efficiency of this type of treatment.
A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.
Each year there are more than three million cases of cholera worldwide, a disease transmitted through contaminated food and water that hits developing countries particularly hard.
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications.
Myotonic dystrophy (DM) is the most common form of genetic muscular dystrophy that begins in adulthood. DM is characterized by progressive muscle wasting and weakness. People with this disorder often have prolonged muscle contractions (myotonic) and are not able to relax certain muscles after use.
Study could pave way for new life-saving treatments to be administered in critical first hour of injury
Scientists hope to have paved the way for the development of potentially new life-saving treatments to be administered to seriously injured patients in the critical first hour of injury.
Nanorods made of bismuth sulfide kill tumor cells with heat when they are irradiated with near-infrared light. Chinese scientists are now making these weapons more powerful by remodeling the defect state of the nanorod crystal lattice by adding gold nanodots.
Limiting the nutrient resources that pathogens depend on for replication could prevent the emergence of drug resistance, according to research findings. In a study published in Proceedings of the National Academy of Sciences, scientists have taken advantage of the competition that occurs between host pathogens to achieve successful treatment of infection with existing drugs, even when drug-resistant pathogens were present.
A group of Salzburg-based researchers led by the psychologist Eva Jonas investigates the neuro-psychological mechanisms behind existential threats. What exactly happens in the process between threat and defensive reaction is at the center of an ongoing study funded by the Austrian Science Fund FWF.
Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new results from two studies with EndoPredict are being featured at the 2017 San Antonio Breast Cancer Symposium in San Antonio, Texas.
Researchers at the University of Montreal Hospital Research Centre have identified a promising solution to improving treatments offered to patients with cystic fibrosis.
Tuberculosis is one of the most widespread life-threatening infectious diseases. Not only does antibiotic resistance make treatment increasingly difficult, but the bacteria’s relatively impermeable mycomembrane also limits the effectiveness of many drugs.
An 80% rise in lung disease admissions to emergency departments in winter plays a major part in pushing our A&E services over the edge. Yet, only 10% of hospital trusts who responded to an FOI request had plans in place to make more beds available for respiratory patients warns a new report from the British Lung Foundation.
Huntington's disease is a neurodegenerative disease. It is always fatal. The disease is caused by a defect in the Huntingtin gene. To this day, no therapy will put a stop to the insidious disintegration of brain cells.
A new phase 2, multi-site trial conducted at the Northwestern Medicine and University of Colorado School of Medicine suggests that for people with early-stage Parkinson's disease, high-intensity exercise three times a week is safe and can delay the worsening of motor symptoms.
Continence problems are among the most common pediatric health problems. It's commonly believed that continence problems resolve with age in all children.